Biotech investing isn’t for the faint of heart — but when it pays off, it can pay big. A single FDA approval or positive clinical trial can transform an under-the-radar biotech into a billion-dollar giant overnight. In 2025, three emerging ...
Biotech investing isn’t for the faint of heart — but when it pays off, it can pay big. A single FDA approval or positive clinical trial can transform an under-the-radar biotech into a billion-dollar giant overnight. In 2025, three emerging ...